0000882104-17-000019.txt : 20170307 0000882104-17-000019.hdr.sgml : 20170307 20170307201811 ACCESSION NUMBER: 0000882104-17-000019 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20170304 FILED AS OF DATE: 20170307 DATE AS OF CHANGE: 20170307 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: PDL BIOPHARMA, INC. CENTRAL INDEX KEY: 0000882104 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 943023969 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 932 SOUTHWOOD BLVD CITY: INCLINE VILLAGE STATE: NV ZIP: 89451 BUSINESS PHONE: 775-832-8500 MAIL ADDRESS: STREET 1: 932 SOUTHWOOD BLVD CITY: INCLINE VILLAGE STATE: NV ZIP: 89451 FORMER COMPANY: FORMER CONFORMED NAME: PROTEIN DESIGN LABS INC/DE DATE OF NAME CHANGE: 19930328 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Hart Danny J Jr. CENTRAL INDEX KEY: 0001518546 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 000-19756 FILM NUMBER: 17673679 MAIL ADDRESS: STREET 1: 932 SOUTHWOOD BOULEVARD CITY: INCLINE VILLAGE STATE: NV ZIP: 89451 4 1 wf-form4_148893587789206.xml FORM 4 X0306 4 2017-03-04 0 0000882104 PDL BIOPHARMA, INC. PDLI 0001518546 Hart Danny J Jr. 932 SOUTHWOOD BOULEVARD INCLINE VILLAGE NV 89451 0 1 0 0 VP Business Development Common stock 2017-03-04 4 A 0 199019 2.04 A 387236 D The restricted stock will vest, provided that the officer remains employed by the Company and certain performance goals are achieved, based upon the following schedule: 50% on December 2018; 16.66% on December 2019; 16.66% on December 2020; and 16.66% on December 2021. /s/ Nathan N. Kryszak, Attorney-in-Fact for Danny J. Hart, Jr. 2017-03-07